1. Home
  2. List
Reference Patent

Reference - List

When you enter multiple keywords separated by space, your search will contain results that match any of the keywords (OR search).
  • 52 Hits
  • Search Condition : Filter (MeSH = Antineoplastic Agents / therapeutic use*)
Species Resource Title
Human and Animal Cells ATDC5(RCB0565) Utilizing BMP-2 muteins for treatment of multiple myeloma.
Human and Animal Cells TGBC2TKB(RCB1130) Targeting the hedgehog pathway for gallbladder cancer therapy?
Human and Animal Cells Colon-26(Colon-26) Evaluation of a combination tumor treatment using thermo-triggered liposomal drug delivery and carbon ion irradiation.
Human and Animal Cells NB1RGB(RCB0222) A novel matrix metalloproteinase inhibitor, FYK-1388 suppresses tumor growth, metastasis and angiogenesis by human fibrosarcoma cell line.
Human and Animal Cells HGC-27(RCB0500) A novel carbazole topoisomerase II poison, ER-37328: potent tumoricidal activity against human solid tumors in vitro and in vivo.
Human and Animal Cells PANC-1(RCB2095) Secalonic acid D as a selective cytotoxic substance on the cancer cells adapted to nutrient starvation.
Human and Animal Cells Colon-26(RCB2657) Lamellarin-inspired potent topoisomerase I inhibitors with the unprecedented benzo[g][1]benzopyrano[4,3-b]indol-6(13H)-one scaffold.
Human and Animal Cells colon-26(RCB2657) Potential Antitumor Activity of 2-O-α-d-Glucopyranosyl-6-O-(2-Pentylheptanoyl)-l-Ascorbic Acid.
Human and Animal Cells JHOS-2(RCB1521) A re-engineered immunotoxin shows promising preclinical activity in ovarian cancer.
Human and Animal Cells PANC-1(RCB2095) The G2 checkpoint inhibitor CBP-93872 increases the sensitivity of colorectal and pancreatic cancer cells to chemotherapy.
Human and Animal Cells B16/BL6(RCB2638) Anti-tumor effects of differentiation-inducing factor-1 in malignant melanoma: GSK-3-mediated inhibition of cell proliferation and GSK-3-independent suppression of cell migration and invasion.
Human and Animal Cells GSU(RCB2278) , H-111-TC(RCB1884) , HGC-27(RCB0500) , MKN7(RCB0999) Influence of the HER receptor ligand system on sensitivity to cetuximab and trastuzumab in gastric cancer cell lines.
Human and Animal Cells TE-5(RCB1949) , TE-8(RCB2098) , TE-10(RCB2099) , TE-1(RCB1894) Novel EGFR-targeted strategy with hybrid peptide against oesophageal squamous cell carcinoma.
Human and Animal Cells TFK-1 (RCB2537) A Histone Deacetylase Inhibitor Suppresses Epithelial-Mesenchymal Transition and Attenuates Chemoresistance in Biliary Tract Cancer.
Mice GFP-LC3#53(RBRC00806) ATG4B inhibitors with a benzotropolone core structure block autophagy and augment efficiency of chemotherapy in mice.
General Microbes JCM 1055 , JCM 1057 , JCM 1149 , JCM 1551 , JCM 6651 , JCM 8341 , JCM 8342 , JCM 8344 Anti-tumor activity of heat-killed Lactobacillus plantarum BF-LP284 on Meth-A tumor cells in BALB/c mice.
Human and Animal Cells Overexpression and gene amplification of EGFR, HER2, and HER3 in biliary tract carcinomas, and the possibility for therapy with the HER2-targeting antibody pertuzumab.
Human and Animal Cells Resveratrol reduces the hypoxia-induced resistance to doxorubicin in breast cancer cells.
Human and Animal Cells Axitinib (AG-013736), an oral specific VEGFR TKI, shows potential therapeutic utility against cholangiocarcinoma.
Human and Animal Cells High antitumor activity of pladienolide B and its derivative in gastric cancer.